CHPA Makes Take-Back Programs Top Policy Targets Outside Washington
This article was originally published in The Tan Sheet
Executive Summary
CHPA will add its voice to the debate over local ordinances that include OTCs in mandatory drug take-back programs, says Carlos Gutierrez, senior director of state government affairs. Identifying the issue as its top non-federal policy fight, CHPA will continue working to educate consumers and support voluntary programs.
You may also be interested in...
CHPA Optimistic Voluntary Drug Takeback Efforts Will Stall Spread Of Mandates
OTC industry trade groups will more aggressively push for an education program to encourage proper disposal of Rx and OTC drugs as states consider mandating industry-funded takeback programs and a patchwork of local ordinances expands.
CHPA Optimistic Voluntary Drug Takeback Efforts Will Stall Spread Of Mandates
OTC industry trade groups will more aggressively push for an education program to encourage proper disposal of Rx and OTC drugs as states consider mandating industry-funded takeback programs and a patchwork of local ordinances expands.
OTC Drug Industry Could Stand To Gain With 'Pragmatist' In White House
With the Trump administration ahead, CHPA's highest regulatory priorities include eliminating a requirement from the Obama era that consumers get a prescription in order to pay for OTC drugs with pre-tax savings accounts and improving the Nixon-era monograph program.